Device maker Medtronic Inc. (NYSE: MDT) reaffirmed its financial projections for fiscal 2011, with revenue growth expected between 5 percent and 8 percent.
The company expects diluted earnings per share between $3.45 and $3.55 for the full year, according to a statement from Medtronic. The consensus analysts’ estimate is earnings per share of $3.51.
For 2010, Medtronic posted diluted earnings per share of $2.79. Revenue grew 8 percent to $15.8 billion.
The Impact Brands: Empowering Wellness Through Natural and Holistic Solutions
In an era of escalating healthcare costs and a growing preference for natural, holistic approaches to health, The Impact Brands emerges as a collective of diverse brands dedicated to supporting overall wellness through natural means.
For the first quarter, the company expects diluted earnings per share between 79 and 81 cents.
Medtronic’s stock was down 2 percent to $37.32 in midday trading.